BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 24617712)

  • 1. Exploring the association Between DICER1 mutations and differentiated thyroid carcinoma.
    de Kock L; Sabbaghian N; Soglio DB; Guillerman RP; Park BK; Chami R; Deal CL; Priest JR; Foulkes WD
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1072-7. PubMed ID: 24617712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DICER1 Mutations and Differentiated Thyroid Carcinoma: Evidence of a Direct Association.
    Rutter MM; Jha P; Schultz KA; Sheil A; Harris AK; Bauer AJ; Field AL; Geller J; Hill DA
    J Clin Endocrinol Metab; 2016 Jan; 101(1):1-5. PubMed ID: 26555935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
    Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M
    Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma.
    Seki M; Yoshida K; Shiraishi Y; Shimamura T; Sato Y; Nishimura R; Okuno Y; Chiba K; Tanaka H; Kato K; Kato M; Hanada R; Nomura Y; Park MJ; Ishida T; Oka A; Igarashi T; Miyano S; Hayashi Y; Ogawa S; Takita J
    Cancer Res; 2014 May; 74(10):2742-9. PubMed ID: 24675358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
    Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
    N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Molecular Characteristics May Alter Treatment Strategies of Thyroid Malignancies in DICER1 Syndrome.
    van der Tuin K; de Kock L; Kamping EJ; Hannema SE; Pouwels MM; Niedziela M; van Wezel T; Hes FJ; Jongmans MC; Foulkes WD; Morreau H
    J Clin Endocrinol Metab; 2019 Feb; 104(2):277-284. PubMed ID: 30260442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep Sequencing Reveals Spatially Distributed Distinct Hot Spot Mutations in DICER1-Related Multinodular Goiter.
    de Kock L; Bah I; Revil T; Bérubé P; Wu MK; Sabbaghian N; Priest JR; Ragoussis J; Foulkes WD
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3637-3645. PubMed ID: 27459524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study.
    Khan NE; Bauer AJ; Schultz KAP; Doros L; Decastro RM; Ling A; Lodish MB; Harney LA; Kase RG; Carr AG; Rossi CT; Field A; Harris AK; Williams GM; Dehner LP; Messinger YH; Hill DA; Stewart DR
    J Clin Endocrinol Metab; 2017 May; 102(5):1614-1622. PubMed ID: 28323992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of somatic and germ-line DICER1 mutations in pleuropulmonary blastoma, cystic nephroma and rhabdomyosarcoma tumors within a DICER1 syndrome pedigree.
    Fernández-Martínez L; Villegas JA; Santamaría Í; Pitiot AS; Alvarado MG; Fernández S; Torres H; Paredes Á; Blay P; Balbín M
    BMC Cancer; 2017 Feb; 17(1):146. PubMed ID: 28222777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline DICER1 mutations and familial cystic nephroma.
    Bahubeshi A; Bal N; Rio Frio T; Hamel N; Pouchet C; Yilmaz A; Bouron-Dal Soglio D; Williams GM; Tischkowitz M; Priest JR; Foulkes WD
    J Med Genet; 2010 Dec; 47(12):863-6. PubMed ID: 21036787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology-histopathology correlation in 7 patients.
    Darbinyan A; Morotti R; Cai G; Prasad ML; Christison-Lagay E; Dinauer C; Adeniran AJ
    Cancer Cytopathol; 2020 Oct; 128(10):746-756. PubMed ID: 32897650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleuropulmonary Blastoma with Hotspot Mutations in RNase IIIb Domain of DICER 1: Clinicopathologic Study of 10 Cases in a Single-Institute Experience.
    Lee M; Kim TI; Jang SJ; Cho KJ; Lee SM; Kim HR; Song JS
    Pathobiology; 2021; 88(3):251-260. PubMed ID: 33567437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations.
    de Kock L; Sabbaghian N; Plourde F; Srivastava A; Weber E; Bouron-Dal Soglio D; Hamel N; Choi JH; Park SH; Deal CL; Kelsey MM; Dishop MK; Esbenshade A; Kuttesch JF; Jacques TS; Perry A; Leichter H; Maeder P; Brundler MA; Warner J; Neal J; Zacharin M; Korbonits M; Cole T; Traunecker H; McLean TW; Rotondo F; Lepage P; Albrecht S; Horvath E; Kovacs K; Priest JR; Foulkes WD
    Acta Neuropathol; 2014 Jul; 128(1):111-22. PubMed ID: 24839956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.
    Rio Frio T; Bahubeshi A; Kanellopoulou C; Hamel N; Niedziela M; Sabbaghian N; Pouchet C; Gilbert L; O'Brien PK; Serfas K; Broderick P; Houlston RS; Lesueur F; Bonora E; Muljo S; Schimke RN; Bouron-Dal Soglio D; Arseneau J; Schultz KA; Priest JR; Nguyen VH; Harach HR; Livingston DM; Foulkes WD; Tischkowitz M
    JAMA; 2011 Jan; 305(1):68-77. PubMed ID: 21205968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal chondromesenchymal hamartomas arise secondary to germline and somatic mutations of DICER1 in the pleuropulmonary blastoma tumor predisposition disorder.
    Stewart DR; Messinger Y; Williams GM; Yang J; Field A; Schultz KA; Harney LA; Doros LA; Dehner LP; Hill DA
    Hum Genet; 2014 Nov; 133(11):1443-50. PubMed ID: 25118636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DICER1 pleuropulmonary blastoma familial tumour predisposition syndrome: What the paediatric urologist needs to know.
    Faure A; Atkinson J; Bouty A; O'Brien M; Levard G; Hutson J; Heloury Y
    J Pediatr Urol; 2016 Feb; 12(1):5-10. PubMed ID: 26454454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
    Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
    JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biallelic DICER1 mutations occur in Wilms tumours.
    Wu MK; Sabbaghian N; Xu B; Addidou-Kalucki S; Bernard C; Zou D; Reeve AE; Eccles MR; Cole C; Choong CS; Charles A; Tan TY; Iglesias DM; Goodyer PR; Foulkes WD
    J Pathol; 2013 Jun; 230(2):154-64. PubMed ID: 23620094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the spectrum of thyroid carcinoma with somatic DICER1 mutation: a survey of 829 thyroid carcinomas using MSK-IMPACT next-generation sequencing platform.
    Ghossein CA; Dogan S; Farhat N; Landa I; Xu B
    Virchows Arch; 2022 Feb; 480(2):293-302. PubMed ID: 34580763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry.
    Schultz KA; Pacheco MC; Yang J; Williams GM; Messinger Y; Hill DA; Dehner LP; Priest JR
    Gynecol Oncol; 2011 Aug; 122(2):246-50. PubMed ID: 21501861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.